Cann Group Ltd. · ASX:CAN
Cann — Shareholder Meeting (November 2021)
25 slides from Cann's shareholder meeting presentation, Nov 10, 2021
Slide 1: AGM Presentation
ASX ANNOUNCEMENT 10 November 2021 For personal use only AGM Presentation 10 November 2021: In advance of this afternoon’s Annual General Meeting of shareholders to be held at 2:00pm, and in accordance with ASX Listing Rule 3.13.3, Cann Group Limited (CAN:ASX) is pleased to provide a copy of the pres
Slide 2: Annual General Meeting
For personal use only Annual General Meeting 2pm Wednesday 10 November, 2021 Allan McCallum, AO | Chairman Peter Crock | CEO
Slide 3: Disclaimer
Disclaimer For personal use only This AGM presentation (Presentation) has been prepared by Cann Group Limited (ABN 25 603 949 739) (Cann). Summary information This Presentation contains summary information about Cann and its activities which is current as at the date of this Presentation. The inform
Slide 4: Agenda
Agenda For personal use only 1 Introduction 2 Chairman’s address 3 CEO’s address 4 Q&A 5 Formal items of business
Slide 5: Our Board & CEO
Our Board & CEO For personal use only MR ALLAN M CCALLUM , AO Chairman M S J E N N I P I LC H E R Non-executive Director MR PHILIP JACOBSEN Deputy Chairman MR JOHN SHARMAN Non-executive Director M R D O U G R AT H B O N E , AM Non-executive Director MR PETER CROCK Chief Executive Officer MR GEOFF PE
Slide 6: Formal business of AGM
For personal use only business of AGM Formal
Slide 7: Financial statements and reports
Item 1 | Financial statements and reports For personal use only To receive the financial report, directors’ report and auditor’s report for the Company and its controlled entities for the financial year ended 30 June 2021.
Slide 8: Chairman's address
For personal use only Chairman’s address Allan McCallum, AO
Slide 9: Growth strategy supported by investors
For personal use only G R O W T H S T R AT E GY SUPPORTED BY INVESTORS Capital raisings pave the way for Cann’s fully integrated supply chain strategy. Corporate TIER 1 BANK DEBT FINANCE growth Secured $50m debt facility with NAB. D E V E LO P I N G A N E N D - T O - E N D C A PA B I L I T Y Cann to
Slide 10: Satipharm acquisition
For personal use only S AT I P H A R M A C Q U I S I T I O N POSITIONS CANN TO: • Access rapidly growing CBD markets. • Fast-track development of THC medicinal cannabis products. Satipharm • Become an Australian leader in the over-the-counter low-dose CBD market.
Slide 11: Mildura facility is nearing completion
For personal use only M I L D U R A FA C I L I T Y I S NEARING COMPLETION Large scale, medical grade, cGMP manufacturing facility. World FOCUS ON IMPROVED class E F F I C I E N C I E S & I N N O VAT I O N facilities U P G R A D E AT S O U T H E R N FA C I L I T Y
Slide 12: iuvo Therapeutics and global demand
For personal use only IUVO THERAPEUTICS • Partnership established with iuvo, a leading German importer & distributor. • Cann delivered first shipment of 20,000 units. Global demand R E G U L AT O R Y C H A N G E S & EVIDENCE CONTINUES TO E V O LV E GROWTH IN DEMAND EXPECTED TO CONTINUE
Slide 13: CEO's address
For personal use only CEO’s address Peter Crock
Slide 14: Mildura nears completion
For personal use only Establishes Cann’s capabilities and scale related efficiencies. Mildura Cultivation, GMP extraction, manufacturing and analytical nears laboratory. completion Aiming to be an employer of choice in the Sunraysia region.
Slide 15: Upgrades and commercial B2B strategy
For personal use only U P G R A D E AT S O U T H E R N FA C I L I T Y E N A B L E S C G M P PA C K E D F LO W E R Upgrades & B 2 B S T R AT E GY C O N T I N U E S WITH EUROPE/UK FOCUS commercial M U LT I P L E R E V E N U E O P P O R T U N I T I E S W I T H LO C A L CUSTOMERS
Slide 16: Satipharm
For personal use only OPENS B2C OPPORTUNITY C A P S U L E T E C H N O LO GY T O P R O M OT E C O N F I D E N C E Satipharm FA S T T R A C K S D E V E LO P M E N T O F T H C - B A S E D F O R M U L AT I O N S S3 OVER-THE-COUNTER OPPORTUNITY PROGRESSING
Slide 17: Research programs and R&D partnerships
For personal use only RESEARCH PROGRAMS EN SURE CANN IS LE ADI NG I N N O VAT I O N I N T H E S E C T O R : • Agriculture Victoria – genetics R&D • La Trobe University – nutrition requirements • NSW DPI – cultivation techniques partnerships • • CSIRO – cannabinoid isolation & manufacturing Monash Me
Slide 18: Outlook FY22
For personal use only C O N T I N UA L LY G R O W I N G A C C E P TA N C E O F M E D I C I N A L CANNABIS M I L D U R A FA C I L I T Y Outlook COMMISSIONING BRINGING FY22 VA R I O U S N E W OPPORTUNITIES FOCUS ON DELIVERY FOR ALL S TA K E H O L D E R S
Slide 19: Q&A
For personal use only Q&A
Slide 20: Items to be voted
For personal use only Resolutions for voting Items 2 to 5
Slide 21: Adoption of Remuneration Report
Resolution 2 | Adoption of Remuneration Report For personal use only That, pursuant to and in accordance with section 250R(2) of the Corporations Act, the Remuneration Report for the financial year ending 30 June 2021 as set out in pages 23 to 32 (inclusive) of the Annual Report be adopted. Proxy vo
Slide 22: Re-election of Director
Resolution 3 | Re-election of Director For personal use only That Mr Doug Rathbone, a Director who retires from office in accordance with Rule 50.2 of the Company’s Constitution and being eligible for re-election, be re-elected a Director of the Company. Proxy votes 52,615,955 3,151,675 1,176,980 56
Slide 23: Re-election of Director
Resolution 4 | Re-election of Director For personal use only That Mr John Sharman, a Director who was appointed to fill a casual vacancy in accordance with Rule 49.1 of the Company’s Constitution until this Annual General Meeting and being eligible for re-election, be re-elected a Director of the Co
Slide 24: Approval of amendments to Constitution
Resolution 5 | Approval of amendments to For personal use only Constitution That, in accordance with section 136(2) of the Corporations Act the Constitution of the Company be amended as set out in the amended Constitution tabled at the Annual General Meeting convened by this Notice of Annual General
Slide 25: Meeting close
For personal use only Meeting close CONTACTS Clive Fanning Head of Investor Relations Cann Group Limited +61 3 9095 7088 contact@canngrouplimited.com Matthew Wright Investor / Media Relations NWR Communications +61 (0)451 896 420 matt@nwrcommunications.com.au